Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -64.4% | +14.5% | 2 / 3 | -81.6% | +238.10 pp | +166.87 pp | -0.3% | 0.11 | 901.83 | 7,6 | −81,6% | 27,2 | −65,6% | 901.83 | 4.50 | +19.940,6% |
| Pts | 0 | 0 | 8 | 0 | 12 | 12 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 6.700 (close price on 2026-10-19)EPS (TTM): 7,4
Financial charts
1.Revenue & growth
VND bn7,56Q2/26
1.Revenue & growth
VND bn7,56Q2/26
2.Profit & growth
VND bn18,2Q2/26
3.Profit mix (Penman)
VND bn-17,5Q2/26
4.Margins & cost structure
%57.3%Q2/26
5.Returns & cash cycle
% · days-13.0%Q2/26
6.Earnings quality & cash
VND bn-1.345Q2/26
7.Asset structure
VND bn1.876Q2/26
8.Funding & debt health
VND bn · times1.876Q2/26
9.Revenue backlog
VND bn0,42Q2/26
10.Valuation
times · %-168,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %189Q2/26
Adjusted EPS growth, latest quarter
-71.8%
Average adjusted EPS growth, 3 quarters
-71.8%
averaged over 1 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q2/26